(NASDAQ: AVR) Anteris Technologies Global's forecast annual revenue growth rate of 64.68% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.9%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.69%.
Anteris Technologies Global's revenue in 2025 is $2,139,112.On average, 3 Wall Street analysts forecast AVR's revenue for 2025 to be $74,897,182, with the lowest AVR revenue forecast at $64,597,790, and the highest AVR revenue forecast at $86,514,897. On average, 3 Wall Street analysts forecast AVR's revenue for 2026 to be $411,934,502, with the lowest AVR revenue forecast at $290,690,054, and the highest AVR revenue forecast at $545,043,851.
In 2027, AVR is forecast to generate $322,494,578 in revenue, with the lowest revenue forecast at $20,186,809 and the highest revenue forecast at $648,861,728.